Hayat Biotech, a leading biotechnology company in the Middle East and North Africa, is collaborating with Pakistan’s Ministry of National Health Services to establish a plasma-farming facility (PFF) in Islamabad. The initiative aims to address the growing concern over a global plasma shortage, which has resulted in a 20% drop in plasma donations between 2020-2021.
A delegation from Dubai, including Ahmed bin Dalmook bin Juma Al Maktoum, a member of Dubai’s ruling family, and Naser Ali Khameis Alyammahi, the Chief Operations Officer of Hayat BioTech, met with Health Minister Abdul Qadir Patel and Prime Minister Shehbaz Sharif to discuss collaboration in the fields of health, vaccine, and research. The delegation inaugurated a coordination office at the Regional Blood Centre in Islamabad, which will work closely with the firm and the ministry to establish a plasma collection centre in Pakistan based on WHO standards.
The absence of a PFF has posed a significant challenge to Pakistan’s patient population, which heavily relies on plasma-based therapies for survival and improved quality of life. Patients with immunodeficiency disorders have to import medicines or proteins from abroad at exorbitant rates, making this initiative a significant development for the country.
Read More: Men often die before women, and the Y chromosome may be to blame
Hayat Biotech is working to establish an end-to-end plasma collection entity within the country, providing plasma-derived pharmaceutical products that treat a wide range of rare, chronic, and potentially life-threatening health conditions. The UAE delegation expressed its commitment to supporting the development and expansion of the project in Pakistan, highlighting the mutual benefit of collaboration in the health field.
The project is expected to contribute to the growth of the plasma collection sector and enhance Pakistan’s healthcare infrastructure. The establishment of a PFF in Islamabad will not only address the plasma shortage in the country but also provide an affordable solution for patients in need of life-saving treatments.
